CD20 antibody variants and uses thereof

Details for Australian Patent Application No. 2006210405 (hide)

Owner Genentech, Inc.

Inventors Nakamura, Gerald R.; Adams, Camellia W.; Lowman, Henry B.

Agent FB Rice

Pub. Number AU-A-2006210405

PCT Pub. Number WO2006/084264

Priority 60/689,404 10.06.05 US; 60/651,111 07.02.05 US; 60/702,571 25.07.05 US

Filing date 6 February 2006

Wipo publication date 10 August 2006

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/084264 Priority application(s): WO2006/084264

1 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210406-11a, 12-derivatives of tetracycline compounds

2006210403-Absorption cycle utilizing ionic liquid as working fluid